Cristal Therapeutics

Cristal Therapeutics

Private
MaastrichtHealthcare & Life Scienceshttps://cristaltherapeutics.com

Last Round

Grant

Jul 2, 2020

Total Funding Raised

$24.08M

Momentum Score

50 /100

Company Overview

Cristal Therapeutics is a biotechnology company that develops nanomedicines and bioconjugation technologies designed to improve targeted therapy for cancer and other diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials, Advanced Materials, Precision Medicine

Business Model

B2B

Customer Profile

Revenue Share, Government Contracts

AI Layer

Non-AI

Keywords

nanomedicinenanoparticle drug deliverydrug delivery technologytargeted drug deliverypolymeric nanoparticlesoncology drug deliveryclinical stage pharmapharma licensingbioconjugation platformclick chemistrysolid tumor therapyantibody-drug conjugatesADCvaccine delivery

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Cristal Therapeutics Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Cristal Therapeutics Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
GrantJul 2, 2020
GrantNov 28, 2017
Series BJan 19, 2017
Series ADec 15, 2014
SeedJul 1, 2013

Key People

Founding team and executive leadership

Werner Cautreels

Chief Executive Officer

Executive Team

Cristal Therapeutics Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Nov 26, 2025

    Partnered with Curapath to expand CliCr(R) platform.

Cristal Therapeutics Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Cristal Therapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Cristal Therapeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersMaastricht
Employee Range4
Year Founded2011
Last FundingJul 2, 2020

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.